Mission

Project 8p’s mission is to create a path to treatment for Chromosome 8p disorders through translational research, building a community, and intelligent information. We are driven by a simple question: What can we do for our child, family member, friend, or patient impacted by this diagnosis? We’re committed to leaving no stone unturned and trying everything we can to help in a meaningful way.

 
 

Letter from the Founder

Dear Friends,

My daughter beams with light and gives hugs to everyone around her, from a stranger to her brother, so long as she senses positivity. Even all of her specialists (over a dozen!) receive a huge embrace with a cheek to-cheek-smile from her. She is smart, and she captivates those around her.

She was born with what appeared to be healthy, except for a rare genetic mutation in the 8th chromosome. Some of her genes are missing, some are duplicated, and some are flipped around.  And nobody has a clue as to how this happened.

 
 

Research towards Treatment

Among the main goals of the Human Genome Project (HGP) was to develop new, better and cheaper tools to identify new genes and to understand their function.

Aligned with Project 8p’s mission of translational research is our ability to fund and welcome partnerships to take clinical action.  With quality data sharing, transparency, and free access to our iPSC lines and open-access mice models and organisms, we encourage researchers around the world to help us discover clinically relevant, medically actionable, stretch of DNA that is the key to help individuals affected by genetic disease, and the “future of medicine” for 8p disorders. 

We invite researchers to help us identify the specific priority genes and which symptoms they are associated with, understand the cause of the genetic mutation, and develop a treatment plan and possible prevention of this disorder.   

We are pragmatic and impatiently patient about the unknown timeline; therefore, we want to start now and be ready to take advantage of the future of genome medicine.